lentinan has been researched along with HIV Coinfection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gohchi, K; Matsuda, J | 1 |
| Baker, M; DeMarzo, C; Goodgame, J; Gordon, M; Guralnik, M; Kaneko, Y; Lang, W; Mimura, T; Pierce, D | 1 |
| Bihari, B; Goosby, E; Gordon, M; Gorter, R; Greco, M; Guralnik, M; Kaneko, Y; Mimura, T; Rudinicki, V; Wong, R | 1 |
2 trial(s) available for lentinan and HIV Coinfection
| Article | Year |
|---|---|
A phase II controlled study of a combination of the immune modulator, lentinan, with didanosine (ddI) in HIV patients with CD4 cells of 200-500/mm3.
Topics: Adjuvants, Immunologic; Adult; CD4 Antigens; Didanosine; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Lentinan; Male; Middle Aged | 1995 |
A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.
Topics: Adjuvants, Immunologic; Adult; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Injections, Intravenous; Lentinan; Male; Middle Aged; Placebos; Thrombocytopenia | 1998 |
1 other study(ies) available for lentinan and HIV Coinfection
| Article | Year |
|---|---|
[Immunotherapy for HIV carrier].
Topics: Carrier State; Ditiocarb; Drugs, Chinese Herbal; Glycyrrhetinic Acid; Glycyrrhizic Acid; HIV Infections; Humans; Immunotherapy; Inosine Pranobex; Lentinan; Poly I-C; Poly U | 1993 |